American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 2,817 | 1,326 | 10 |
| Receivables | 1,762 | 1,199 | 3 |
| Inventories | 496 | 604 | 20 |
| Income taxes - deferred | 69 | 103 | N/A |
| Other current assets | 722 | 596 | -3 |
| TOTAL | $5,864 | $3,827 | $30 |
| Non-Current Assets | |||
| PPE Net | 4,261 | 4,043 | 20 |
| Other Non-Current Assets | 723 | 813 | 1 |
| TOTAL | $4,984 | $4,857 | $21 |
| Total Assets | $10,848 | $8,683 | $60 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 582 | 430 | 180 |
| Accrued Expenses | N/A | N/A | 70 |
| Other current liabilities | 336 | 407 | 0 |
| TOTAL | $2,413 | $2,370 | $330 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 0 | 240 |
| TOTAL | $N/A | $N/A | $240 |
| Total Liabilities | $2,413 | $2,370 | $570 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 11 | 10 | N/A |
| Common Shares | 11 | N/A | 30 |
| Retained earnings | 3,826 | N/A | -1,830 |
| Other shareholders' equity | 0 | 6,313 | 10 |
| TOTAL | $8,435 | $6,313 | $-510 |
| Total Liabilities And Equity | $10,848 | $8,684 | $60 |